 Heron Therapeutics Inc NASDAQ: HRTX has announced the online publication of a new analysis from the Phase 3 EPOCH 1 and EPOCH 2 studies evaluating Zynrelef bupivacaine and meloxicam in adults aged 65 years and older after bunionectomy and hernia repair. Zynrelef is an extended-release solution of bupivacaine and meloxicam indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia. 